Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
YES....we are in the WTF faze right now
Is that red I see? So much for BOOOOOMMM!!!!!
ALRIGHT!!! HUGE GAP UP AT OPEN!!! UNBELIEVABLE VOLUME!!! Look at all those new investors chomping at the bits to get on board after seeing a film made by college students!!!!
Just another carrot dangled in our face. Can't sell BIG NEWS is coming. Typical Pump and Dump.
Except that the Green Assets said it will be investing in PROFITABLE mmj businesses, which CBIS is not.
Just like they were crushed when the biopsy came out. LOL
You don't call going from 250 mil A/S to 850 mil A/S dilution?
what kind of company announced a dividend and still doesn't deliver a year and a half later?
http://www.cannabisscience.com/investor/sec-filing.html
it is from the one they filled in November. Just wait for the 10k, gonna be UGLY!!!
Since it shows on their website that only 86 people bothered to read their last financlial filling (10 q) filed in November here is the link
http://www.cannabisscience.com/download/nov2111_10q.pdf
So whoever says there is no dilution going on..Do your DD.
2. GOING CONCERN
The accompanying financial statements have been prepared in conformity with U.S. generally accepted accounting principles, which contemplate the continuation of the Company as a going concern. The Company reported an accumulated deficit of
$68,139,436 and had a stockholder’s deficit of $2,038,474 at September 30, 2011.
In view of the matters described, there is substantial doubt as to the Company's ability to continue as a going concern without a significant infusion of capital. At September 30, 2011, the Company had minimal operations. There can be no assurance
that management will be successful in implementing its plans. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
We anticipate that we will have to raise additional capital to fund operations over the next 12 months. To the extent that we are required to raise additional funds to acquire research and growing facilities, and to cover costs of operations, we intend to do
so through additional public or private offerings of debt or equity securities. There are no commitments or arrangements for other offerings in place, no guaranties that any such financings would be forthcoming, or as to the terms of any such
financings. Any future financing may involve substantial dilution to existing investors. We had been relying on our common stock to pay third parties for services which has resulted in substantial dilution to existing investors.
3. RELATED PARTY TRANSACTIONS
As of September 30, 2011, a total of $156,818 (December 31, 2010: $107,835) was due to a related party. The amounts due are non-interest bearing, unsecured and have no specified terms of repayment. This
related party also performs management services to the Company under a management consulting agreement signed on July 1, 2010.
4. NOTES PAYABLE
As of September 30, 2011, a total of $188,055 (December 31, 2010: $171,509) of notes payable are due to stockholders. A total of $9 is due to a stockholder under a convertible note that is non-interest bearing and has no specified terms of repayment.
$188,046 is due to stockholders under promissory notes that are non-interested bearing and are due 12 months from the date of issue and loan origination beginning on July 30, 2011 through June 29, 2012. One of the stockholders, to whom $184,200 in
promissory notes are payable, also performs business and accounting services for the Company on a month-to-month basis.
5. COMMON STOCK
During the three-months ended September 30, 2011, the Company issued the following common stock:
On July 26, 2011, the Company issued 1,400,000 common shares, with a fair market value of $0.04 per share, for settlement of $1,400 of shareholder debt assigned from the shareholder note payable originating on December 16, 2010 and owing at
December 31, 2010.
On July 27, 2011, the Company issued 6,000,000 common shares, with a fair market value of $0.04 per share, for settlement of $6,000 of shareholder debt assigned from the shareholder note payable originating on July 9, 2010 and July 15, 2010 and
owing at December 31, 2010.
On July 28, 2011, the Company issued 3,000,000 common shares, with a fair market value of $0.05 per share, for settlement of $3,000 of shareholder debt assigned from the shareholder note payable originating on July 9, 2010 and owing at December
31, 2010.
On August 8, 2011, the Company issued 3,400,000 common shares, with a fair market value of $0.04 per share, for settlement of $3,400 of shareholder debt assigned from the shareholder note payable originating on December 16, 2010 and owing at
December 31, 2010.
On August 16, 2011, the Company issued 3,000,000 common shares, with a fair market value of $0.04 per share, for settlement of $3,000 of shareholder debt assigned from the shareholder note payable originating on August 16, 2010 and owing at
December 31, 2010.
On September 6, 2011, the Company issued 3,500,000 common shares, with a fair market value of $0.03 per share, for settlement of $3,500 of shareholder debt assigned from the shareholder note payable originating on July 15, 2010 and owing at
December 31, 2010.
On September 14, 2011, the Company issued 3,000,000 common shares, with a fair market value of $0.03 per share, for settlement of $3,000 of shareholder debt assigned from the shareholder note payable originating on July 30, 2010 and owing at
December 31, 2010.
On September 22, 2011, the Company issued 3,500,000 common shares with a fair market value of $105,000 to a consultant for services rendered to the Company; pursuant to a consulting agreement entered into on August 10, 2011 with services to be
provided through August 31, 2013.
F-7
On August 10, 2011, the Company signed a Consulting Agreement with a Consultant. Under the Agreement, the Company shall issue up to $250,000 of common shares, based on the current market price of the Company’s stock, to the Consultant for
services rendered from August 10, 2011 to August 31, 2013. On September 22, 2011 the Company issued 3,500,000 common shares as an initial payment under the Agreement.
9. SUBSEQUENT EVENTS
On October 4, 2011, the Company issued 6,500,000 common shares with a fair market value of $156,000 to two consultants for services rendered to the Company. 3,500,000 were issued to the same consultant that previously received shares on
September 22, 2011 and 3,000,000 shares were issued to a consulting for services rendered to the Company for the period October 1, 2011 to September 30, 2012.
On October 12, 2011, the Company issued 8,000,000 common shares, with a fair market value of $0.022 per share, for settlement of $8,000 of shareholder debt assigned from the shareholder notes payable originating on July 9, 2010, July 15, 2010, and
July 30, 2010 and owing at December 31, 2010.
On October 13, 2011, the Company issued 3,000,000 common shares, with a fair market value of $0.0224 per share, for settlement of $3,000 of shareholder debt assigned from the shareholder note payable originating on March 2, 2011.
On October 13, 2011, the Company issued 4,500,000 common shares with a fair market value of $100,800 to a consultant for services rendered to the Company for the period October 15, 2011 to October 14, 2012.
On October 25, 2011, the Company issued 300,000 common shares with a fair market value of $0.02 per share for the settlement of $300 of shareholder debt assigned from the shareholder note payable originating on July 15, 2010 and owing at
December 31, 2010.
On October 25, 2011, the Company issued 5,500,000 common shares with a fair market value of $0.03 per share for the settlement of $5,500 of shareholder debt assigned from the shareholder note payable originating on July 30, 2010 and August 5,
2010 and owing at December 31, 2010.
On November 4, 2011, the Company issued 30,000,000 common shares with a fair market value of $0.03 per share for the settlement of $5,500 of shareholder debt assigned from the shareholder note payable originating on September 2, 2010, September
17, 2010, and October 7, 2010 and owing at December 31, 2010.
Authorized Share Increase
On November 4, 2011, the Company filed a a Certificate of Amendment to increase the authorized number of shares to 951 million comprised of: 100 million Class A Common Stock, 850 million Class B Common Stock, and 1 million Series A Preferred
Stock.
F-8
I don't understand what you mean. The Divy will be of a new class of shares. Plus they have been doling out shares like candy. They doll out shares with a market value of 10X what they owed to pay for shareholder debt.
I have some set at 16, some at 15. Im in at 11. I also sold some at 17.
It is in the 10q. If also says under subsequent events between the end of qtr and time of filling they voted to raise the a/s to 850 mil. At this pace of dillution, I bet the next filling will shoe 1.5 billion shares
Also people have stated that financials don't matter. IT sure does, eventually money out with no money in leads to bankruptcy. How long can you continue to pay people in Shares? Also the dilition doesn't matter...ever hear of supply and demand? Yes it would be wonderfull if this is indead a cancer cure, but alot of good it would do this company since they can't patent it.
It also said it that report that the company is unlikely to survive unless they get a large cash influx. Now I know everyone is speculating on green assets, but NO WHERE did green assets say they are investing in CBIS. They also but in there that under subequesnt events that they authorised the A/S to increase to 850 mil. I think the A/S is going to be over 1 billion on the next report. Plus they also do not have any products for sale. The only product they have on there website is Medical Marijuana.
Also, they say the cancer patients are self admnistering Cannabis extracts, does not even say that these extracts are provided by CBIS or if the patients are ONLY using these extracts and not receiving other treatments as well. Also, these patients are using nothing more then Hash oil, which anyone can make themselves, there are videos on youtube, and also it is already being sold in dispensories. It was even in a episode or American Weed. CBIS has no proprietory formula, no patents and no products. Look out people, the CBIS sky is about to fall. IF I am wrong, great!! People will be healed and I will make $$ as I still hold a good amount of shares, but I am protecting myself with stop orders and I already took profits.
This is all MHO
Blast me as a basher, I am not a shorty, I hope that they succede, but investing with my eyes open and not drinking the Kool Aid.
Did anyone notice that on the 10 q filed in Sep 2011 there were 250 mil A/S and now on their website it say 800 mil? Did anyone notice that they are dolling out millions of shares to people that they owed $1000 to? Wish I could do $1000 worth of work and get paid several million shares worth tens of thousands of dollars now worth hundreds of thousands of dollars. Also the jump from 250 mil shares to 800 mil? Talk about dilution. Stop orders set, will ride the pump but will be out when the dump occurs.
As I read it, the Divy is only for shareholders of record who owned the stock on Dec 31 2010. If you didn't own it then, you won't get Divy. If you owned it at close of day that day, you will get divy even if you sold subsequent, just like any other stock.
Legal under state law..illegal under fed law. Anyday the DEA can shut them down.
Hate to tell you but that is not a real medical journal. It is just a website sponsored by Martin Keane. It is a holistic and alternative website not a peer reviewed journal. If this was i. A peer reviewed journal, then
it would be big, other than that, it is irrelevant.
How can CBIS make any money of something that the US Government ownes the patent for?
http://ricksimpsonhempoil.blogspot.com/2011/12/us-government-licenses-patent-for.html
Show me where it says they actually FILED. Doesn't it say INTEND to file?
Also interesting to note, they never say their ointment is the ONLY treatment these patients are using. They could be using meds in conjunction with the oil. They need to do double blind studies and have it published in a peer reviewed journal for it to have any real credibility. Also someone stated, why would they lie about it? If they did then the company would be toast. What a company never exagerated a claim in penny world to pump up a stock price then DUMP the shares in penny world before?
first off, I am not a short, and two, I am not emotional. Just stating my perspective and I am opening my eyes to the fact that this is starting to seem more like a pump and dump everyday. I will ride the wave, hopefully I am wrong. I will cash out profits and let my free shares ride all the while I will protet myself with stop orders.
still holding on, glad to take some money and let the rest ride for now. I hope it does work and they are successful. Not just for my wallet but for people with cancer. Just saying, just because they put out news, doesn't mean it is accurate. Ride the wave and take profits when you can.
READ MY WORDS!!! WHERE ARE THE ACTUAL BIOPSIES. Hey we have biopsy results...I also have a bridge to sell you. Anyone can say we have something. If you do, show us. Until then it is just anecdotal evidence and means shit.
What words. Where is the actual report from an oncologist? Anyone can put out a PR saying the cancer is gone. Show the proof.
That is pictures. Where is an actual pathology report signed by a doctor saying clean biopsy? Pictures can lie.
I agree. Sold some shares at .17. Have a stop at .16 for some more and will hold my free shares for as long as I can if in fact this company is for real.
Another "rumor" of huge cash coming in!! And what does she get in exchange...DILUTED SHARES to dump after the pump
none of those articles say what actual patents they have just "patents' I want to see patent ID numbers to see what patents they own. Anyone can say in a fluff pr that we have patents. Ok show me what they are.
They can post path report. They don't need patients permission, they just have to black out patients personal data. I want to see what they have patented and I want to see path reports from a credible source and put in a peer reviewed medical journal. Until then it is just a story.
Because it is all the diluted shares being dumped.
If they have the patents, what are the patent numbers?
Question? Do they ALREADY have any patents? If not, anyone can make what they are making. Someone call IR and get the patent numbers so we can look up and see what patents they actually do own.
had a stop in @.17. Sold 1/3 of my shares for a nice little profit. Have another stop in for 1/3 of my shares at .16. I am losing confidence in this stock as they are betting the farm on a product they can't patent. Hemp oil is easy to make and that is all they are using. Big pharma won't buy them out, they will just make their own version of hemp oil. It I found out olive oil cured cancer, can I patent it? NO!. This seems like a pump and dump. All the signs are there, reverse buyout, paying people with shares, fluffy PR's...etc. The dump is coming.